What Is the FDA?

The Food and Drug Administration (FDA) is the U.S. federal regulatory agency responsible for ensuring the safety, efficacy, and security of human and animal drugs, biological products, medical devices, food, cosmetics, and radiation-emitting products. It operates within the Department of Health and Human Services and exercises authority under the Federal Food, Drug, and Cosmetic Act and a series of subsequent amendments. In the engineering and technology communities, the FDA is most consequential as the gatekeeper for medical devices: virtually every hardware or software product intended for diagnostic or therapeutic use in humans requires FDA clearance or approval before it can be sold or distributed in the United States.

The FDA's scope over technology has grown substantially since the Medical Device Amendments of 1976, which first gave the agency formal premarket authority over devices. Subsequent legislation, including the Safe Medical Devices Act of 1990 and the 21st Century Cures Act of 2016, progressively extended FDA oversight to software, digital health tools, and artificial intelligence systems used in clinical decision-making.

Medical Device Classification and Approval Pathways

The FDA classifies medical devices into three tiers based on risk. Class I devices, such as tongue depressors and elastic bandages, face general controls only. Class II devices, covering a large portion of diagnostics, imaging systems, and powered surgical tools, are typically cleared through the 510(k) premarket notification pathway, which requires demonstrating substantial equivalence to a legally marketed predicate device. Class III devices, including implantable pacemakers, defibrillators, and deep brain stimulators, require premarket approval (PMA), the most rigorous review pathway, which demands valid scientific evidence of safety and effectiveness from controlled clinical trials.

FDA regulatory requirements for medical devices with control algorithms receive particular scrutiny because software defects in a closed-loop control system can produce harmful outcomes. The agency's guidance documents on software as a medical device and the Software Development Life Cycle detail what design controls, hazard analyses, and verification and validation records developers must maintain to support a submission.

Standards, Cybersecurity, and Emerging Technologies

The FDA recognizes and sometimes co-develops technical standards as tools for meeting its requirements. IEEE standards in the FDA's recognized standards database allow manufacturers to demonstrate conformance to design control and performance requirements by testing against defined criteria rather than negotiating device-specific protocols with reviewers. In recent years, cybersecurity has become a prominent requirement: FDA guidance issued in 2023 requires manufacturers to submit a software bill of materials, a vulnerability disclosure policy, and evidence of post-market cybersecurity monitoring as part of any new device submission.

Artificial intelligence and machine learning in medical devices present ongoing regulatory challenges because adaptive algorithms can change their behavior after deployment, potentially moving outside the performance envelope validated in the original submission. The FDA has published a proposed regulatory framework for AI and ML-based software and has worked with IEEE and other standards bodies to build technical foundations for premarket review and post-market surveillance of adaptive systems.

Applications

The FDA's regulatory framework applies across a range of fields, including:

• Implantable and wearable medical devices such as cardiac monitors, insulin pumps, and cochlear implants
• In vitro diagnostic equipment including laboratory analyzers, point-of-care tests, and sequencing instruments
• Radiation-emitting products such as X-ray systems, CT scanners, and laser devices
• Digital health applications and clinical decision support software meeting the software-as-a-medical-device definition
• Drug delivery systems integrating hardware, firmware, and pharmaceutical formulations